Idarubicin
Catalog No: FT-0621481
CAS No: 58957-92-9
- Molecular Formula: 497.5
- Formula Weight: C26H27NO9
- Inchl Key: XDXDZDZNSLXDNA-TZNDIEGXSA-N
- Inchl: InChI=1S/C26H27NO9/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3/t10-,15-,16-,17-,21+,26-/m0/s1
| Assay | Pack | Price | Stock | Action |
|---|---|---|---|---|
| 98% | 1g | N/A | N/A | |
| 98% | 5g | N/A | N/A | |
| 98% | Bulk Quantity | N/A | N/A |
| Melting_Point: | N/A |
|---|---|
| CAS: | 58957-92-9 |
| MF: | C26H27NO9 |
| Flash_Point: | 392.5±32.9 °C |
| Product_Name: | Idarubicin |
| Density: | 1.6±0.1 g/cm3 |
| FW: | 497.494 |
| Bolling_Point: | 725.4±60.0 °C at 760 mmHg |
| Refractive_Index: | 1.706 |
|---|---|
| Vapor_Pressure: | 0.0±2.5 mmHg at 25°C |
| Flash_Point: | 392.5±32.9 °C |
| LogP: | 2.95 |
| Bolling_Point: | 725.4±60.0 °C at 760 mmHg |
| FW: | 497.494 |
| PSA: | 176.61000 |
| Computational_Chemistry: | ['1. XlogP :N/A ', '2. Hydrogen Bond Donor Count :5 ', '3. Hydrogen Bond Acceptor Count :10 ', '4. Rotatable Bond Count :3 ', '5. Isotope Atom Count :54 ', '6. TPSA 177 ', '7. Heavy Atom Count :36 ', '8. Topological Polar Surface Area :0 ', '9. Complexity :912 ', '10. Isotope Atom Count :0 ', '11. Defined Atom Stereocenter Count :6 ', '12. Undefined Atom Stereocenter Count :0 ', '13. Defined Bond Stereocenter Count :0 ', '14. Undefined Bond Stereocenter Count :0 ', '15. Covalently-Bonded Unit Count :1'] |
| MF: | C26H27NO9 |
| Exact_Mass: | 497.168579 |
| Density: | 1.6±0.1 g/cm3 |
| Risk_Statements(EU): | 60-61-28-40 |
|---|---|
| WGK_Germany: | 3 |
| RTECS: | HB7877000 |
| RIDADR: | UN 2811 6.1/PG 2 |
| Hazard_Codes: | T+ |
| Safety_Statements: | S53-S45 |
Related Products
3,4-Pyrrolidinediol, 2-[(4-methoxyphenyl)methyl]-, 3-acetate, (2S,3R,4R)-
(4S)-2-[[[(2R)-2-AMino-2-(4-hydroxyphenyl)acetyl]aMino]Methyl]-5,5-diMethyl-4-thiazolidinecarboxylic Acid (Mixture of DiastereoMers)